[ET Net News Agency, 30 August 2019] Hansoh Pharmaceutical Group Company Limited
(03692) said its profit attributable to owners of the parent was RMB1.3 billion for the
six months ended 30 June 2019, a year-on-year increase of 24.34%. The earnings per share
were RMB0.25. No interim dividend will be distributed.
The revenue was RMB4.6 billion, a year-on-year increase of 21.86%. The gross profit was
RMB4.22 billion, a year-on-year increase of 19.68%. (RC)